AVTR
Price
$14.78
Change
+$0.21 (+1.44%)
Updated
Oct 17 closing price
Capitalization
10.08B
11 days until earnings call
TFX
Price
$128.13
Change
+$4.25 (+3.43%)
Updated
Oct 17 closing price
Capitalization
5.66B
5 days until earnings call
Interact to see
Advertisement

AVTR vs TFX

Header iconAVTR vs TFX Comparison
Open Charts AVTR vs TFXBanner chart's image
Avantor
Price$14.78
Change+$0.21 (+1.44%)
Volume$13.17M
Capitalization10.08B
Teleflex
Price$128.13
Change+$4.25 (+3.43%)
Volume$599.51K
Capitalization5.66B
AVTR vs TFX Comparison Chart in %
AVTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTR vs. TFX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTR is a Hold and TFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (AVTR: $14.57 vs. TFX: $128.13)
Brand notoriety: AVTR and TFX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVTR: 177% vs. TFX: 103%
Market capitalization -- AVTR: $10.08B vs. TFX: $5.66B
AVTR [@Pharmaceuticals: Other] is valued at $10.08B. TFX’s [@Pharmaceuticals: Other] market capitalization is $5.66B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $159.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTR’s FA Score shows that 0 FA rating(s) are green whileTFX’s FA Score has 1 green FA rating(s).

  • AVTR’s FA Score: 0 green, 5 red.
  • TFX’s FA Score: 1 green, 4 red.
According to our system of comparison, TFX is a better buy in the long-term than AVTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTR’s TA Score shows that 5 TA indicator(s) are bullish while TFX’s TA Score has 6 bullish TA indicator(s).

  • AVTR’s TA Score: 5 bullish, 5 bearish.
  • TFX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TFX is a better buy in the short-term than AVTR.

Price Growth

AVTR (@Pharmaceuticals: Other) experienced а +7.61% price change this week, while TFX (@Pharmaceuticals: Other) price change was +7.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.75%. For the same industry, the average monthly price growth was +0.04%, and the average quarterly price growth was +13.98%.

Reported Earning Dates

AVTR is expected to report earnings on Oct 29, 2025.

TFX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.75% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTR($10.1B) has a higher market cap than TFX($5.66B). TFX has higher P/E ratio than AVTR: TFX (29.87) vs AVTR (14.63). TFX YTD gains are higher at: -27.434 vs. AVTR (-29.853). AVTR has higher annual earnings (EBITDA): 1.41B vs. TFX (601M). AVTR has more cash in the bank: 449M vs. TFX (254M). TFX has less debt than AVTR: TFX (2B) vs AVTR (4.24B). AVTR has higher revenues than TFX: AVTR (6.67B) vs TFX (3.04B).
AVTRTFXAVTR / TFX
Capitalization10.1B5.66B178%
EBITDA1.41B601M235%
Gain YTD-29.853-27.434109%
P/E Ratio14.6329.8749%
Revenue6.67B3.04B219%
Total Cash449M254M177%
Total Debt4.24B2B213%
FUNDAMENTALS RATINGS
AVTR vs TFX: Fundamental Ratings
AVTR
TFX
OUTLOOK RATING
1..100
1412
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9041
P/E GROWTH RATING
1..100
9985
SEASONALITY SCORE
1..100
5045

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (28) in the Medical Specialties industry is somewhat better than the same rating for AVTR (71) in the null industry. This means that TFX’s stock grew somewhat faster than AVTR’s over the last 12 months.

TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AVTR (100) in the null industry. This means that TFX’s stock grew similarly to AVTR’s over the last 12 months.

TFX's SMR Rating (100) in the Medical Specialties industry is in the same range as AVTR (100) in the null industry. This means that TFX’s stock grew similarly to AVTR’s over the last 12 months.

TFX's Price Growth Rating (41) in the Medical Specialties industry is somewhat better than the same rating for AVTR (90) in the null industry. This means that TFX’s stock grew somewhat faster than AVTR’s over the last 12 months.

TFX's P/E Growth Rating (85) in the Medical Specialties industry is in the same range as AVTR (99) in the null industry. This means that TFX’s stock grew similarly to AVTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTRTFX
RSI
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
56%
Momentum
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 5 days ago
63%
Bullish Trend 5 days ago
54%
Declines
ODDS (%)
Bearish Trend 9 days ago
72%
Bearish Trend 9 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
69%
Aroon
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
AVTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.510.10
+0.43%
Bright Rock Quality Large Cap Instl
HMVJX16.080.04
+0.25%
Hartford MidCap Value I
APHMX48.340.07
+0.15%
Artisan Mid Cap Institutional
FBGKX257.03N/A
N/A
Fidelity Blue Chip Growth K
DPREX13.50-0.04
-0.30%
Macquarie Global Listed Real Assets A

AVTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTR has been loosely correlated with ATR. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTR jumps, then ATR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTR
1D Price
Change %
AVTR100%
+1.44%
ATR - AVTR
57%
Loosely correlated
+0.14%
RGEN - AVTR
50%
Loosely correlated
-1.26%
AZTA - AVTR
47%
Loosely correlated
-1.68%
SOLV - AVTR
45%
Loosely correlated
+1.01%
TFX - AVTR
40%
Loosely correlated
+3.43%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
+3.43%
A - TFX
51%
Loosely correlated
+0.58%
BDX - TFX
50%
Loosely correlated
+2.07%
RVTY - TFX
47%
Loosely correlated
-0.54%
TNDM - TFX
44%
Loosely correlated
-3.27%
AZTA - TFX
44%
Loosely correlated
-1.68%
More